Alaunos Therapeutics, Inc.
TCRT
$1.55
-$0.02-1.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -952.00K | -1.01M | -893.00K | -1.16M | -1.05M |
| Total Depreciation and Amortization | 9.00K | 8.00K | 7.00K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 247.00K | 141.00K | 243.00K | 301.00K | 215.00K |
| Change in Net Operating Assets | 396.00K | -174.00K | 91.00K | 14.00K | 135.00K |
| Cash from Operations | -300.00K | -1.03M | -552.00K | -844.00K | -701.00K |
| Capital Expenditure | -- | -- | -1.00K | -97.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -1.00K | -97.00K | -- |
| Total Debt Issued | 70.00K | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 1.91M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 1.35M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 70.00K | -- | 0.00 | 0.00 | 3.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -230.00K | -1.03M | -553.00K | -941.00K | 2.56M |